Leadership & Pay ·
Ionis Pharmaceuticals appoints Ludwig N. Hantson to Board of Directors
IONSIonis Pharmaceuticals Inc
Ionis Pharmaceuticals, Inc. announced the appointment of Ludwig N. Hantson to the Board of Directors, effective June 4, 2026. The Company's 2026 Annual Meeting of Stockholders held on June 4, 2026, resulted in the approval of several proposals, including the election of directors and advisory vote on executive compensation, and amendments to equity incentive and employee stock purchase plans.